2025 Regular Session • Nevada Legislature
AB555: Establishes provisions relating to the coverage of prescription insulin drugs under certain policies of health insurance. (BDR 57-1167)
Legislative Summary
AN ACT relating to insurance; establishing a maximum cost-sharing amount that certain health insurers may impose for a 30-day supply of prescription insulin drugs; and providing other matters properly relating thereto.
Demographic Impact
Overall analysis of equity impact
90% Positive
High ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
5/8/2025
Read first time. Referred to Committee on Commerce and Labor. To printer.
Assembly
5/9/2025
From printer. To committee.
Assembly
5/22/2025
From committee: Do pass.
Assembly
5/22/2025
Placed on Second Reading File.
Assembly
5/22/2025
Read second time.
Assembly
5/23/2025
Read third time. Passed. Title approved. (Yeas: 42, Nays: None.) To Senate.
Assembly
5/23/2025
In Senate.
Senate
5/23/2025
Read first time. Referred to Committee on Commerce and Labor. To committee.
Senate
5/28/2025
From committee: Do pass.
Senate
5/28/2025
Placed on Second Reading File.
Senate
5/28/2025
Read second time.
Senate
5/29/2025
Read third time. Passed. Title approved. (Yeas: 18, Nays: 2, Excused: 1.) To Assembly.
Senate
5/30/2025
In Assembly. To enrollment.
Assembly
Roll Call Votes
Senate Final Passage
5/29/2025
18
Yea
2
Nay
0
Not Voting
1
Absent
Result: PASSED
Assembly Final Passage
5/23/2025
42
Yea
0
Nay
0
Not Voting
0
Absent
Result: PASSED
Status Information
Current Status
Engrossed(5/23/2025)
Chamber
Assembly
Sponsors
Democrat: 1
Primary Sponsor
Steve Yeager
Democrat